Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's disease
Pharma
AZ's China deals, Kailera-Hengrui—Fierce Pharma Asia
AZ signed billion-dollar licensing deals with CSPC and Sino Biopharm. Hengrui and Kaleira's oral GLP-1 reported China phase 3 results.
Angus Liu
Jul 10, 2026 8:51am
Eli Lilly taps AI to bring personal memories to life
Jun 26, 2026 9:59am
Fosun Pharma plots global push, fueled by Alzheimer’s deals
Jun 25, 2026 7:00pm
Eisai gets UK backing as it expands plant for Leqembi production
Jun 15, 2026 10:20am
Lilly yells ‘action’ on authentic patient portrayals at Tribeca
Jun 10, 2026 5:30pm
Eisai whips up Alzheimer’s guidance to expand nutrition program
Jun 2, 2026 5:44am
